Since the inception of rituximab in the 1990s, anti-CD20 monoclonal antibodies have
revolutionised the treatment of B cell hematological malignancies and have become a …

The pervasive application of chimeric antigen receptor (CAR)-based cellular therapies in the
treatment of oncological diseases has long been recognized. However, CAR T cells can …

ABSTRACT Introduction: Lupus Nephritis (LN) is a severe manifestation of Systemic Lupus
Erythematosus (SLE) with a significant prognostic impact. Over a prolonged course, an …

Autoimmune diseases are caused by a dysfunction of the acquired immune system. In a
subset of autoimmune diseases, B cells escaping immune tolerance present autoantigen …

Background Warm autoimmune hemolytic anemia (w-AIHA) is an uncommon disease with
heterogeneous response to treatment. Steroids are the standard treatment at diagnosis …

Autoimmune hemolytic anemia (AIHA) is a rare hematologic disease, primarily affecting
adults or children with immunodeficiency disease. First-line therapy consists of long course …

Introduction: Chronic lymphocytic leukemia (CLL), the most common leukemia in Western
countries, is a mature B-cell chronic lymphoproliferative disorder characterized by the …

初诊伴自身免疫性溶血性贫血的侵袭性非霍奇金淋巴瘤特征分析 首页 期刊简介 1.期刊介绍 2.获奖
情况 编委会 期刊在线 1.最新录用 2.优先发表 3.当期目录 4.过刊浏览 视频合辑 在线投稿 1.投稿 …

Drug-induced immune hemolytic anemia (DIIHA) is a relatively uncommon cause of anemia,
and its diagnosis can be challenging. Although beta-lactam antimicrobial agents are often …

Castlemans disease (CD) is a rare lymphoproliferative disorder. Concurrent autoimmune
disease and CD are uncommon, but even more so, comorbid CD and autoimmune …